跳至主要内容
临床试验/NCT01859897
NCT01859897已完成不适用

A Prospective Multicenter Study to Evaluate Usefulness of Cardio-Ankle Vascular Index in Japan

CAVI-J Study Group1 个研究点 分布在 1 个国家目标入组 3,026 人开始时间: 2013年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
3,026
试验地点
1
主要终点
major cardiac events

研究概览

简要总结

The objective of this five-year prospective observational follow-up study is to examine the additional benefits of using cardio-ankle vascular index (CAVI) as a predictive indicator of cardiovascular events in high-risk patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
40 Years 至 74 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients between 40 and 74 years of age who have either of the following:
  • Type 2 diabetes mellitus
  • Metabolic syndrome
  • Grade I to III hypertension with the third layer of risk factors according to the guidelines for the management of hypertension japanese society of hypertension(JSH)2009
  • Chronic kidney disease(stage G3a or G3b) according ot the clinical Practice Guidebook for Diagnosis and Treatment of Chronic Kidney Disease 2012 in Japan
  • History of coronary artery disease or noncardiogenic cerebral infarction

排除标准

  • Under 40 years of age or over 74 years of age
  • An ankle-brachial index less than 0.9
  • Chronic atrial fibrillation
  • Current symptoms of heart failure(NYHA class III or IV) or left ventricular dysfunction (EF below 40%)
  • Chronic kidney disease(G4 or G5)according ot the clinical Practice Guidebook for Diagnosis and Treatment of Chronic Kidney Disease 2012 in Japan
  • chronic dialysis due to renal failure
  • Taking steroids/immunosuppressants
  • Hepatocirrhosis

结局指标

主要结局

major cardiac events

时间窗: five years

cardiac death, nonfatal myocardial infarction, stroke

次要结局

  • all cause mortality, cardiovascular events, and renaly dysfunction(five years)

研究者

发起方
CAVI-J Study Group
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

CAVI-J Study Group

CAVI-J study Group

Okayama University

研究点 (1)

Loading locations...

相似试验